there is a new weight loss drug in town American Farmer company Eli Lily has rolled out a new strategy to widen the availability and affordability of its popular weight loss drug Zep bound the farmer giant has begun selling starter doses of its Zep Bound in a single dose vial here rather than using an injector pen that is already filled with medications patient will be pulling out the medication using a syringe interestingly the vial will cost half of the price of its original injectable pen now Z bound is typically sold in auto injector pens but with easier to manufacture and fill vials the company will be able to get the drug to patients more quickly eventually the move will allow the company to expand Supply on the back of high demand [Music] [Music] Z bound known scientifically as tepati is part of a class of drugs called glp1 receptor agnostics which have garnered attention for their effectiveness in promoting weight loss these medications work by mimicking hormones that regulate appetite and Insulin release helping patients feel Fuller and reduce their calorie intake as per the company while a 4-we supply of 2.5 MGR vial is $399 a 4-we supply of 5 mgram is $529 now these vials are available through companies direct to Consumer website Lily direct to increase their availability in the marketplace the new Wilds will be available exclusively to people who pay out of their pocket patients will also be able to buy supplies like syringes and needles at the same time now besides these prices are in line with those offered through Lily's saving program for uninsured people according to a company executive the new vials will help the company broaden access for patients seeking a safe and effective treatment option talking about the efficiency of the newly launched medication uh the company said that a clinical study shows a 5 mgram maintenance dose help patients achieve an average of 15% weight loss after 72 weeks of [Music] treatment it has been a powerful tool for millions of people with obesity looking to lose weight the recent move puts Eli Lily ahead of its rival Novo nisk in terms of capacity boosting to put things in perspective Eli Lily has been facing intense competition from cheaper weight loss drugs